Sign In

Patrick Hlavacek

Director, HEOR @ Pfizer

Patrick Hlavacek is a professional with a diverse educational background and extensive experience in Health Economics and Outcomes Research (HEOR) within the pharmaceutical industry.

He holds a Master of Public Health (M.P.H.) in Epidemiology from Columbia University Mailman School of Public Health, a Bachelor of Arts (B.A.) in Psychology from Kalamazoo College, and has pursued additional studies in Health Economics at the University of York and Cognitive Science at Eötvös Loránd University.

Patrick has held several key roles at Pfizer, including Director of HEOR for Hematology, Director and Senior Manager of HEOR for Eliquis, Manager of HEOR for Bococizumab and Pain Portfolio, and Research Associate in the area of Pain Portfolio.

His experience also includes research assistant positions at Columbia University Irving Medical Center and the Mailman School of Public Health, focusing on outcomes research and innovation.

With his strong academic foundation and years of practical experience in HEOR, Patrick Hlavacek brings a wealth of knowledge and expertise to the field of pharmaceutical research and healthcare economics.

Highlights

Patient and economic burdens of postherpetic neuralgia in China | CEOR - Dove Medical Press
Epidemiology of physician-diagnosed neuropathic pain in Brazil | JPR - Dove Medical Press
Patrick Hlavacek
Add to my network

Location

New York, New York, United States